287

We have developed a convenient and sensitive assay for the measurement of mTOR activity. A GST fusion of the classical mTOR substrate p70S6K is pre-bound to a microtiter plate coated with glutathione. mTOR-containing sample is then added to the sample well in the presence of ATP and manganese containing assay buffer. Active mTOR phosphorylates p70S6K at Thr389. The phosphorylated substrate is detected with a phosphospecific anti-p70S6K(T389) antibody, followed by detection with HRP-antibody conjugate and relative activity is determined by reading absorbance. Using the assay we are able to measure kinase activity of a partially purified mTOR standard generated from an enriched rat brain fraction. The enriched mTOR standard contains both mTOR/Raptor and mTOR/Rictor complexes. The detected mTOR activity is inhibited by the general PI-3K inhibitor wortmannin as well as rapamycin/FKBP12 (IC50 of 8 nM), a specific inhibitor of the mTOR/Raptor complex. The assay was miniaturized to a well volume of 20ul using a 384 well plate format and a fluorescent HRP substrate to improve sensitivity and dynamics. Additionally we detect mTOR activity associated with various mTOR complexes immunoprecipitated from crude 293 cell lysates. Unlike the mTOR /Rictor complex, immunoprecipitation of active mTOR/Raptor requires the use of a CHAPS containing lysis buffer to ensure capture of the intact complex. Phosphorylation of Ser473 on Akt was used to analyze the kinase activity associated with the mTOR/Rictor complex. The described non-radioactive assays are useful for in vitro mTOR inhibitor screening and for assessing the regulation of mTOR in cell signaling.

98th AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA